a preliminary description of ongoing studies of the tissue concentrations of fura and metabolites in human colorectal carcinoma and in adjacent normal bowel after rapid injection and after 24-hour infusion of radiolabelled pharmacologically active doses of fura is included as one approach to learning more about the cellular pharmacology of fluorinated pyrimidines .
C0009402
colorectal carcinoma
C0021853
bowel